Galantas Gold Corporation (LON:GAL) said it has reached a formal agreement with the Police Service of Northern Ireland (PSNI) which can allow blasting to take place at the Omagh gold mine. The company noted that the agreement creates the potential for a materially improved economic arrangement for an expansion of underground blasting, which is necessary if the Omagh mine is to achieve full commercial production. “The agreement is the result of detailed cooperation between Galantas & PSNI and I am pleased that the new arrangements, in which the company has heavily invested, have been formalized in this way,” said Roland Phelps, Galantas chief executive in a statement.
4D pharma PLC (LON:DDDD) has updated investors on activities in the development program for its immune-oncology single strain live biotherapeutic candidate MRx0518. The AIM-listed firm said MRx0518 is in an ongoing Phase I/II clinical trial in combination with immune checkpoint inhibitor (ICI) Keytruda (pembrolizumab), in patients with advanced malignancies who have previously progressed on ICI therapy. The study is comprised of two parts – Part A, an initial safety phase assessing dose-limiting toxicities of the combination which was completed in May last year, and the Part B cohort expansion phase to assess clinical benefit in addition to safety which has begun.
Oriole Resources PLC (LON:ORR) said it has been awarded five new licences in Central Cameroon which significantly expand the company’s footprint in the country. The company highlighted that the new acreage alongside three other licences awarded to Oriole’s partner Reservoir Minerals Cameroon represents a contiguous, district-scale land package. It spans some 3,592 square kilometres (km2) of what it described as highly prospective geological terrane.
Argo Blockchain PLC (LON:ARB) has updated on its cryptocurrency mining operations for the first month of 2021, highlighting higher revenues and expanded margins over the period. The company reported that its mining revenues for January were £2.48mln. up from £1.63mln in December, while its average monthly mining margin rose to 71% from 60% a month ago.
Directa Plus PLC (LON:DCTA) said it has received a grant for its face masks as part of the European Union’s Horizon 2020 research and innovation programme. The producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets said the grant has a total value of €100,000, on a non-refundable basis, and covers a project which is expected to be concluded within the next 8 months. As part of the Inno4Cov-19 Project, the grant will be used to assist Directa’s research into using graphene technology to help prevent the spread of coronavirus (COVID-19).
SIMEC Atlantis Energy Limited (LON:SAE) said it welcomes the report by Newport City Council (NCC) regarding its application for the February Planning Committee meeting and its recommendation for granting permission. The renewable and sustainable energy projects developer said the proposed development in this planning application comprises fuel storage, material handling and other ancillary infrastructure to be constructed external to the existing power station building.
Guild Esports PLC (LON:GILD) said it has signed Tai Starčič, also known as TaySon, Europe’s top-ranked professional Fortnite player, as the fourth member of its esports team for the game. The company said TaySon’s signing elevates its team to the top spot in the region from second place, adding that TaySon has “immense popularity at a grassroots level” having recently been named ‘Player of the Year’ in the 2020 Competitive Awards for Fortnite as voted for by fans. TaySon has signed a one-year contract with Guild with an option to renew for another year. He will compete under the Guild banner in all upcoming European and international Fortnite tournaments, starting with the new FNCS EU season on February 5.
Applied Graphene Materials PLC (LON:AGM) said its customer, European car products maker Infinity Wax, has launched a second product enhanced with the company’s graphene technology. The AIM-listed firm said the new product, Graphene Wax, uses its Genable graphene nanoplatelet dispersions technology and was launched on January 28, 2021, following the successful release of the first product, QDX Graphene Detailing Spray, in the fourth quarter of 2020.
Power Metal Resources PLC (LON:POW) said its Australian joint venture Red Rock Australasia (RRAL) has started groundwork on its tenements near Ballarat in the Victoria Goldfields. RRAL was granted exploration permits at three licences earlier this week covering 215 sq km in its central to south Ballarat project area. These tenements (along with current applications) surround and overlie the existing Ballarat West and Ballarat East mineralized lode systems, Power Metal said.
Open Orphan PLC (LON:ORPH) said its hVIVO division has opened a new quarantine clinic in East London. The new 19-bedroom Whitechapel Clinic is directly opposite the Queen Mary BioEnterprise Innovation Centre (QMB), which houses hVIVO’s state-of-the-art FluCamp. The converted former boutique hotel will be used as an additional unit for human challenge trials and volunteer recruitment screening. There are quarantine rooms across three floors, with each level fully converted to include a nurses’ station. In a separate statement, Open Orphan PLC said it had received notice of exercise of warrants by investors who participated in the Venn loan note financing in December 2018 over 1,349,349 ordinary shares of 0.1p each in the capital of the company at a price of 0.1p per share for 477,703 ordinary shares and at a price of 2.2 p per share for 871,646 ordinary shares. The gross proceeds of this exercise received by the company amounts to £19,653.91.
Stobart Group PLC (LON:STOB), the aviation and energy infrastructure group has announced that its general meeting held on Wednesday saw the resolution to change the company’s name passed by the required majority by means of a poll. As a result, Stobart Group Limited will now change its name to Esken Limited and the company’s stock market ticker will become ESKN from 8.00am. on February 4, 2021, while its ISIN will remain unchanged.
World High Life PLC (LON:LIFE) said it has appointed Tony Calamita, one of the founders of its subsidiary Love Hemp Limited, as its chief executive and as a director with immediate effect. The cannabidiol (CBD) specialist said Calamita has “played a crucial role in the rapid development of Love Hemp’s business”, creating what it said is “one of the UK’s leading CBD and health and wellness suppliers”.
Destiny Pharma PLC (LON:DEST) said Brazil’s Industrial Property Office has granted it an additional patent over XF-73, a nasal gel being developed to prevent post-surgical infections such as MRSA. The Brazilian authorities have issued what is known as a notice of allowance pending full approval next month. It will be the 84th patent from three patent families covering the XF platform. In the same announcement, Destiny said it expects to share the results of its ongoing phase IIb trial towards the end of March, after which it will concentrate its efforts on a phase III programme.
Scancell Holdings PLC (LON:SCLP) has said it would either develop its cancer immunotherapy in-house or with a new partner after ending a clinical development tie-up with Cancer Research UK (CRUK). The decision to curtail clinical development work on Scancell target SCIB2 followed a re-assessment of the charity’s collaboration model in the wake of the coronavirus pandemic, the company said. CRUK was due to fund and sponsor a phase I/II trial of SCIB2 in combination with a checkpoint inhibitor drug in patients with solid tumours.
Curzon Energy PLC (LON:CZN) has reset its reboot, and is now set to be the vehicle for a British plastic recycling business. The company told investors it has terminated its letter of intent with Sun Seven Stars Investment Group (SSSIG), a move that closes the door on the previously proposed and protracted deal for the London Critical Metals Market (LCMM). Curzon has, at the same time, announced the signing of a separate letter of intent with Poseidon Enhanced Technologies Limited. The Poseidon deal envisages a reverse takeover which would see the AIM-quoted entity become a producer of low-cost recycled plastics for the food and beverage industry.
Sensyne Health PLC (LON:SENS) has launched the first operational AI algorithm for coronavirus (COVID-19) patients built on its SENSE engine. SYNE-OPS-1 was co-developed with the Chelsea & Westminster Hospital NHS Foundation Trust, which has now integrated the system and is using it to manage COVID-19 patients in its intensive care unit.
Zaim Credit Systems PLC (LON:ZAIM), the Russia-focused microloans group, said it increased lending by 65% in the fourth quarter of 2020 as it switched its business online. Loans issued over the three month period were £3.8mln compared to £2.3mln in the previous quarter, with a 250% jump in online borrowing to £2.9mln. Online now comprise 76% of the loan book, Zaim said, which added that the group continued to trade profitably in the fourth quarter.
Digitalbox PLC (LON:DBOX), the mobile-first digital media business has appointed Marcus Rich as its new chairman. Rich, who joins on February 17, 2021, was most recently chief executive of TI Media and led the sale of NME.com to Bandlab Technologies, and oversaw the overall sale of the business to Future PLC. He replaces Robin Miller, who made the decision to step down in October last year.
Bacanora Lithium PLC (LON:BCN) said it has successfully raised USS$65mln via an equity funding comprising a share placing and a retail offer. Some 106.9mln new shares are being issued at a price of 45p each, a 19.6% discount to Tuesday’s mid-market closing price. Chief executive Peter Secker, in a statement, noted that the funding was the final piece in the company’s financing commitment to bring Stage 1 of Sonora into production. “This successful fundraising will allow the company to achieve its ambition of becoming an international lithium production company,” Secker said.
Minds + Machines Group Limited (LON:MMX), one of the world’s leading owners and operators of Internet Top-Level Domains (TLDs) said, further to the announcement of January 25, 2021, it has confirmed the appointment of Tony Farrow as its CEO to the company’s board. It noted that Farrow holds 750,000 ordinary shares of no par value in the company and 750,000 restricted stock units over ordinary shares.
Power Metal Resources PLC (LON:POW) the AIM-listed metals exploration and development company said it has received notices to exercise warrants over 13,295,000 new ordinary shares of 0.1 pence each in the company, with 10,795,000 warrants exercised at a price of 1.0p per ordinary share and 2,500,000 warrants exercised at a price of 0.7p each. Subscription monies of £125,450 have been received by Power Metal in respect of these exercises.
Sunrise Resources PLC (LON:SRES), the AIM-traded company focusing on the development of its CS Pozzolan-Perlite Project in Nevada, USA, announced that it has received notice to exercise 750,000 warrants which entitle the holder to subscribe for one new ordinary share of 0.1p each in the company at a price of 0.16p per warrant share.
Zephyr Energy PLC (LON:ZPHR), the Rocky Mountain oil and gas company focused on responsible resource development, announced that it has received notice of exercise for warrants (issued in October 2020) to subscribe for 1,100,000 new ordinary shares of 0.1p each in the company at a price of 0.6875p per ordinary share.
MaxCyte (LON:MXCT) (LON:MXCL), a global cell-engineering and life sciences company, has announced the appointment of Stifel Nicolaus Europe as the company’s joint corporate broker with immediate effect alongside existing joint corporate brokers Panmure Gordon and Numis.
AdEPT Technology PLC (LON:ADT) has said it is presenting at the MelloMonday event on February 8, 2021, via Zoom Webinar. It noted that Phil Race, CEO and John Swaite, CFO will be presenting to participants and taking questions during the event.
Tiziana Life Sciences PLC (NASDAQ:TLSA) (LON:TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, said an interview with Dr Kunwar Shailubhai, its CEO and CSO, is now available online via the following link: https://www.youtube.com/watch?v=UocEGvQ10OE. In the interview, D. Shailubhai discusses the positive effect of nasally administered Foralumab in coronavirus (COVID-19) mediated pulmonary and systemic inflammation and its potential related to newly identified COVID-19 variants in UK, South Africa, and Brazil. He also comments on the nearly 2x improvement shown in CT scans of the lungs of patients treated with Foralumab as compared to those in the control group.